Gene Review:
MMP3 - matrix metallopeptidase 3 (stromelysin 1,...
Bos taurus
- Effect of hypoxia and reoxygenation on gene expression and response to interleukin-1 in cultured articular chondrocytes. Martin, G., Andriamanalijaona, R., Grässel, S., Dreier, R., Mathy-Hartert, M., Bogdanowicz, P., Boumédiene, K., Henrotin, Y., Bruckner, P., Pujol, J.P. Arthritis Rheum. (2004)
- Increased stromelysin-1 (MMP-3), proteoglycan degradation (3B3- and 7D4) and collagen damage in cyclically load-injured articular cartilage. Lin, P.M., Chen, C.T., Torzilli, P.A. Osteoarthr. Cartil. (2004)
- Hyaluronan oligosaccharide-induced activation of transcription factors in bovine articular chondrocytes. Ohno, S., Im, H.J., Knudson, C.B., Knudson, W. Arthritis Rheum. (2005)
- Mechanical injury of cartilage explants causes specific time-dependent changes in chondrocyte gene expression. Lee, J.H., Fitzgerald, J.B., Dimicco, M.A., Grodzinsky, A.J. Arthritis Rheum. (2005)
- Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Pufe, T., Lemke, A., Kurz, B., Petersen, W., Tillmann, B., Grodzinsky, A.J., Mentlein, R. Am. J. Pathol. (2004)
- Proline-rich tyrosine kinase 2 and Src kinase signaling transduce monosodium urate crystal-induced nitric oxide production and matrix metalloproteinase 3 expression in chondrocytes. Liu, R., Lioté, F., Rose, D.M., Merz, D., Terkeltaub, R. Arthritis Rheum. (2004)
- Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1. Sadowski, T., Steinmeyer, J. Inflamm. Res. (2001)
- Induction of MMP-3 by hyaluronan oligosaccharides in temporomandibular joint chondrocytes. Ohno, S., Ohno-Nakahara, M., Knudson, C.B., Knudson, W. J. Dent. Res. (2005)
- Identification of the metalloproteinase stromelysin in the physis. Armstrong, A.L., Barrach, H.J., Ehrlich, M.G. J. Orthop. Res. (2002)
- Design and synthesis of piperazine-based matrix metalloproteinase inhibitors. Cheng, M., De, B., Pikul, S., Almstead, N.G., Natchus, M.G., Anastasio, M.V., McPhail, S.J., Snider, C.E., Taiwo, Y.O., Chen, L., Dunaway, C.M., Gu, F., Dowty, M.E., Mieling, G.E., Janusz, M.J., Wang-Weigand, S. J. Med. Chem. (2000)
- A matrix metalloproteinase proenzyme activator produced by articular cartilage. Towle, C.A., Wright, M., Hecht, A.C., Kuong, S.J., Papanicolas, L.E., Totkovic, R., Mankin, H.J., Treadwell, B.V. Biochem. Biophys. Res. Commun. (1998)
- Effects of polysulfated glycosaminoglycan and triamcinolone acetonid on the production of proteinases and their inhibitors by IL-1alpha treated articular chondrocytes. Sadowski, T., Steinmeyer, J. Biochem. Pharmacol. (2002)
- Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1-challenged bovine articular cartilage explants. Chan, P.S., Caron, J.P., Orth, M.W. Am. J. Vet. Res. (2005)
- Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes. Sadowski, T., Steinmeyer, J. Osteoarthr. Cartil. (2001)